TherapeuticsMD (TXMD) Reports Q2 EPS of $0.05
Tweet
Share
E-mail
Get Alerts TXMD Hot Sheet
Join SI Premium – FREE
TherapeuticsMD (NASDAQ: TXMD) reported Q2 EPS of $0.05.
For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates
- AMN Healthcare (AMN) Reiterated at Market Outperform by Citizens
- JPMorgan Upgrades IBM (IBM) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
